The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study | The Journal of Headache and Pain | Full Text

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study | The Journal of Headache and Pain | Full Text

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

We evaluated the efficacy of fremanezumab, a fully humanized monoclonal antibody that selectively targets calcitonin gene-related peptide, in patients with chronic migraine (CM) with and without medication ove...

Authors:Stephen D. Silberstein, Joshua M. Cohen, Michael J. Seminerio, Ronghua Yang, Sait Ashina and Zaza Katsarava

Citation:The Journal of Headache and Pain 2020 21:114

Content type:Research article

 

Published on: 21 September 2020

• ViewFull Text
 
• ViewPDF